Cargando…
The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease
Parkinson's disease (PD) is a chronic neurodegenerative disorder that is characterized by motor symptoms as a result of a loss of dopaminergic neurons in the substantia nigra pars compacta (SNc), accompanied by chronic neuroinflammation, oxidative stress, formation of α-synuclein aggregates. Ce...
Autores principales: | Zhang, Chenyu, Zhao, Miao, Wang, Bingwei, Su, Zhijie, Guo, Bingbing, Qin, Lihua, Zhang, Weiguang, Zheng, Ruimao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487081/ https://www.ncbi.nlm.nih.gov/pubmed/34600334 http://dx.doi.org/10.1016/j.redox.2021.102134 |
Ejemplares similares
-
The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease
por: Zhao, Miao, et al.
Publicado: (2021) -
Celastrol prevents high‐fat diet‐induced obesity by promoting white adipose tissue browning
por: Wang, Bingwei, et al.
Publicado: (2021) -
RIIβ‐PKA in GABAergic Neurons of Dorsal Median Hypothalamus Governs White Adipose Browning
por: Wang, Bingwei, et al.
Publicado: (2022) -
Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017) -
Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)